Cancer/Tumor Markers


The only patented* assay targeting the core of the molecule (145-245), Cisbio’s Chromoa R assay offers exceptional sensitivity, specificity, and reproducibility by using two monoclonal antibodies to measure intact and fragmented Chromogranin A (CgA). This enhances the reliability of results.


The Fujirebio Diagnostics, Inc MESOMARK™ assay is the first serum based biomarker sensitive for mesothelioma. It has been developed for the measurement of Soluble Mesothelin-Related Peptide (SMRP) in serum. It can be followed over time and may be useful to assist in the diagnosis of mesothelioma and for the monitoring of patients with confirmed mesothelioma.